Penghui Zhou, Ph.D.
Affiliations: | 2009 | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Cell Biology, ImmunologyGoogle:
"Penghui Zhou"Parents
Sign in to add mentor| Steven L. Kunkel | grad student | 2009 | University of Michigan | |
| (Enhanced anti-tumor immunity by breaking immune tolerance.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Luo F, Li H, Ma W, et al. (2023) The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation. Cellular & Molecular Immunology |
| Zhang X, Cheng L, Gao C, et al. (2023) Androgen Signaling Contributes to Sex Differences in Cancer by Inhibiting NF-κB Activation in T Cells and Suppressing Anti-Tumor Immunity. Cancer Research |
| Deng P, Wang Z, Chen J, et al. (2022) RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer. The Journal of Clinical Investigation |
| Chen Z, Luo Z, Zhang D, et al. (2022) TIGER: A Web Portal of Tumor Immunotherapy Gene Expression Resource. Genomics, Proteomics & Bioinformatics |
| Xiong X, Chen S, Shen J, et al. (2022) Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2. Signal Transduction and Targeted Therapy. 7: 99 |
| He J, Xiong X, Yang H, et al. (2022) Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response. Cell Research |
| Zhou Q, Liang J, Yang T, et al. (2021) Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. Embo Molecular Medicine. e14502 |
| Yang J, Yang X, Pan W, et al. (2021) Fucoidan-Supplemented Diet Potentiates Immune Checkpoint Blockage by Enhancing Antitumor Immunity. Frontiers in Cell and Developmental Biology. 9: 733246 |
| Xu F, Wang Z, Zhang H, et al. (2021) Mevalonate blockade in cancer cells triggers CLEC9A+ dendritic cell-mediated antitumor immunity. Cancer Research |
| Sui Q, Liu D, Jiang W, et al. (2021) Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer. Journal For Immunotherapy of Cancer. 9 |